Assiut University

🇪🇬Egypt

Country: 🇪🇬Egypt

Ownership: Private

Established: 1957-10-01

Employees: 5K

Market Cap: -

Website: http://www.aun.edu.eg

Clinical Trials

Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery

Phase 1

Completed

Conditions: Acute Pain
Chronic Pain

Interventions: Drug: paravertebral block

First Posted Date: 2015-06-04

Last Posted Date: 2017-07-02

Lead Sponsor: Assiut University

Target Recruit Count: 90

Registration Number: NCT02462681

Locations: 🇪🇬
Assiut University, Assiut, Egypt

Topical Ketamine Versus Caudal Ketamine for Postoperative Analgesia in Children Undergoing Inguinal Herniotomy

Phase 2

Completed

Conditions: Postoperative Pain

Interventions: Drug: Ketamine
Drug: Bupivacaine

First Posted Date: 2015-06-03

Last Posted Date: 2015-10-02

Lead Sponsor: Assiut University

Target Recruit Count: 80

Registration Number: NCT02462174

Locations: 🇪🇬
Assiut university hospitals, Assiut, Assiut governorate, Egypt

Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain

Phase 2

Conditions: Therapy
Pain Management

Interventions: Procedure: intrathecal drug administration
Drug: Dexmedetomidine
Drug: ketamine
Drug: Bupivacaine

First Posted Date: 2015-05-28

Last Posted Date: 2015-05-28

Lead Sponsor: Assiut University

Target Recruit Count: 90

Registration Number: NCT02455609

Effect of Morphine, Tramadol, and Ketorolac on Postoperative Stress and Immune Responses

Phase 2

Conditions: Breast Cancer

Interventions: Drug: Intravenous morphine sulphate
Drug: Intravenous ketorolac tromethamine
Drug: Intravenous tramadol HCL

First Posted Date: 2015-05-21

Last Posted Date: 2015-05-21

Lead Sponsor: Assiut University

Target Recruit Count: 60

Registration Number: NCT02449954

Combined Intrathecal Morphine and Dexmedetomidine Analgesia

Phase 2

Completed

Conditions: Postoperative Pain

Interventions: Drug: Dexmedetomidine (Precedex)
Drug: Morphine
Drug: Bupivacaine

First Posted Date: 2015-05-06

Last Posted Date: 2015-05-06

Lead Sponsor: Assiut University

Target Recruit Count: 90

Registration Number: NCT02435537

Balloon Tamponade for Atonic Primary Postpartum Hemorrhage

Not Applicable

Completed

Conditions: Postpartum Hemorrhage

Interventions: Device: Condom loaded foley's catheter
Device: Bakri balloon

First Posted Date: 2015-04-30

Last Posted Date: 2017-11-22

Lead Sponsor: Assiut University

Target Recruit Count: 66

Registration Number: NCT02430155

Letrozole in Assisted Reproductive Technology

Phase 2

Conditions: to Evaluate Letrozole as a Modality for Minimal Ovarian Stimulation in ICSI Cycles .

Interventions: Drug: Letrezole plus FSH
Drug: Standard protocol for induction of ovulation

First Posted Date: 2015-04-29

Last Posted Date: 2016-07-15

Lead Sponsor: Assiut University

Target Recruit Count: 80

Registration Number: NCT02429999

Locations: 🇪🇬
of Medicine, Assiut, Egypt

Role of Ginkgo Biloba Extract in IUGR

Phase 2

Completed

Conditions: Intrauterine Growth Restriction (IUGR)

Interventions: Other: Placebo
Drug: Ginkgo Biloba Extract

First Posted Date: 2015-04-24

Last Posted Date: 2016-03-22

Lead Sponsor: Assiut University

Target Recruit Count: 226

Registration Number: NCT02425436

Misoprostol Prior to Intrauterine Contraceptive Device Insertion

Phase 1

Completed

Conditions: Pain Prior to IUD Insertion

Interventions: Drug: Misoprostol
Drug: Placebo

First Posted Date: 2015-04-08

Last Posted Date: 2016-06-01

Lead Sponsor: Assiut University

Target Recruit Count: 140

Registration Number: NCT02412033

Prevention of POV After Paediatric Tonsillectomy

Phase 4

Completed

Conditions: Vomiting

Interventions: Device: Acupuncture
Drug: Dexamethasone

First Posted Date: 2015-03-13

Last Posted Date: 2016-01-22

Lead Sponsor: Assiut University

Target Recruit Count: 120

Registration Number: NCT02387918

Locations: 🇪🇬
Faculty of Medicine Assuit University, Egypt, Assuit, Egypt

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy